Faculty

Institution

Unit

Venue

Avraham Raz

Professor

Wayne State University

Affiliations

School of Medicine

Oncology

Avraham Raz is currently serving as an Oncology Professor at Wayne State University.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Avraham Raz

Wayne State University

Professor

You can click a keyword to filter the displayed items

oncology cancer research cancer biology tumor biology pharmacology cell biology medicinal research immunology medicine metastasis gene expression cancer treatment cancer care protein science membrane biology cell regulation cancer genomics breast cancer cancer cells cell signaling enzyme inhibition tumor targeting autocrine motility factor vascular biology cellular therapy molecular cancer melanoma cancer genetics molecular regulation protein function cell death leukemia cancer management molecular physiology apoptosis cancer growth biological chemistry anti-cancer agents oncogenes mammalian biology cell motility molecular cell biology cellular physiology skin cancer biomolecular interactions breast oncology cellular biology angiogenesis genitourinary cancers tumor cells breast cancer cells protein phosphorylation cancer risk protein chemistry cell migration endocrine oncology differential expression biological function cytokines clinical mycology biomedical research in vivo systems cell proliferation oncogenic agent differential interaction tumor progression endogenous lectins tumor cell motility modified citrus pectin cell cycle arrest novel substrate citrus pectin lung colonization murine macrophages pituitary tumors metastatic cells carbohydrate recognition malignant disease pathology

Notable Scholarly Works

Notable Federal Grants

Collaborators

Data From Autocrine Motility Factor Promotes Her2 Cleavage and Signaling in Breast Cancer Cells. (2023)

Dhong Hyo KhoPratima Nangia-MakkerVitaly BalanVictor HoganLarry TaitYi WangAvraham Raz

breast cancer cellstumor biologysignaling pathwayscancer researchcancer biologycell biologycell signalingautocrine motility factorsignal transductionbreast cancer

Data From Galectin-3 Cleavage Alters Bone Remodeling: Different Outcomes in Breast and Prostate Cancer Skeletal Metastasis. (2023)

Kosei NakajimaDhong Hyo KhoTakashi YanagawaYosuke HarazonoVictor HoganWei ChenRouba Ali-FehmiRohit MehraAvraham Raz

clinical evidencebreast oncologyleukemiapharmacologycellular therapycancer researchoncologycohort studiesbone remodelingtissue engineeringgeneticsbone researchimmunologyvascular biologybreast cancersurgical oncologybone metabolismregenerative medicinedifferent outcomes

Kenneth V. Honn, Ph.D. (1946–2023). Cancer and Metastasis Reviews (2023)

Avraham RazJohn C. CrissmanCaryn Volpe

metastasiscancer researchradiation oncologyoncologycancer biology

Supplementary Figure 1 From Down-Regulation of Phosphoglucose Isomerase/Autocrine Motility Factor Results in Mesenchymal-To-Epithelial Transition of Human Lung Fibrosarcoma Cells. (2023)

Tatsuyoshi FunasakaHuankai HuTakashi YanagawaVictor HoganAvraham Raz

lung cancercancer biologycell biologypharmacologyrespiratory medicinerna biologygene expressiontumor biologycellular therapycell regulationcell motilitymembrane biologymesenchymal-to-epithelial transitionredox biologyvascular biologytissue (biology)cancer growthdermatologythoracic oncology

Supplementary Figure 1 From Phosphoglucose Isomerase/Autocrine Motility Factor Mediates Epithelial and Mesenchymal Phenotype Conversions in Breast Cancer. (2023)

Tatsuyoshi FunasakaVictor HoganAvraham Raz

cancer biologycell biologybreast oncologypharmacologygene expressionmesenchymal phenotype conversionstumor biologycellular therapyenzymescancer genomicstumor targetingbreast cancergynecologic oncologymedicinal researchsurgical oncologycancer growthendocrinologycancer cellsmolecular biology

Supplementary Figure 1 From Regulation of Phosphoglucose Isomerase/Autocrine Motility Factor Activities by the Poly(Adp-Ribose) Polymerase Family-14. (2023)

Takashi YanagawaTatsuyoshi FunasakaSoichi TsutsumiHuankai HuHideomi WatanabeAvraham Raz

enzymesendocrinologyprotein sciencemolecular regulationbiochemistrypharmacologymembrane biologyphysiologymolecular physiology

Supplementary Figure 3 From Autocrine Motility Factor Promotes Her2 Cleavage and Signaling in Breast Cancer Cells. (2023)

Dhong Hyo KhoPratima Nangia-MakkerVitaly BalanVictor HoganLarry TaitYi WangAvraham Raz

breast cancer cellssignaling pathwayscancer researchcancer biologycell biologycell signalingautocrine motility factorsignal transductiongene expressionbreast cancer

Supplementary Materials and Methods From Galectin-3 Cleavage Alters Bone Remodeling: Different Outcomes in Breast and Prostate Cancer Skeletal Metastasis. (2023)

Kosei NakajimaDhong Hyo KhoTakashi YanagawaYosuke HarazonoVictor HoganWei ChenRouba Ali-FehmiRohit MehraAvraham Raz

breast oncologysynthetic bone substitutemammalian biologybone repairorthopaedic researchurologycellular therapycancer researchbone remodelingtissue engineeringbone researchimmunologyvascular biologytissue (biology)tumor targetingorthopaedic surgeryregenerative medicinedifferent outcomesprostate cancersupplementary materials

Supplementary Tables 1-2 From Racial Disparity in Breast Cancer and Functional Germ Line Mutation in Galectin-3 (Rs4644): A Pilot Study. (2023)

Vitaly BalanPratima Nangia-MakkerAnn G. SchwartzYoung Suk JungLarry TaitVictor HoganTirza RazYi WangZeng Quan YangGen Sheng WuYongjun GuoHuixiang LiJudith AbramsFergus J. CouchWilma L. LingleRicardo V. LloydStephen P. EthierMichael A. TainskyAvraham Raz

hepatologyurologycancer genomicsgeneticscancer imagingoncologycancer researchcancer biologyleukemiacancer disparitiesmedical geneticspharmacologyvascular biologycancer geneticspilot studyhuman geneticsbreast cancerracial disparity

Chimeric Galectin-3 and Collagens: Biomarkers and Potential Therapeutic Targets in Fibroproliferative Diseases. Journal of Biological Chemistry (2022)

Pratima Nangia-MakkerVictor HoganVitaly BalanAvraham Raz

enzymesgene expressionmedicinal chemistryprotein sciencebiological inorganic chemistrypotential therapeutic targetsredox biologybiological chemistrybiochemistrypharmacologyfibroproliferative diseasesmolecular biologyclinical biochemistrymolecular medicinemedicinal researchbiomarkers

1
2
3
4
5
26
10 / page

Avraham Raz

Professor

Wayne State University

Affiliations

School of Medicine

Oncology

Avraham Raz is currently serving as an Oncology Professor at Wayne State University.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Avraham Raz

Wayne State University

Professor

You can click a keyword to filter the displayed items

Notable Scholarly Works

Notable Federal Grants

Collaborators

Data From Autocrine Motility Factor Promotes Her2 Cleavage and Signaling in Breast Cancer Cells. (2023)

Dhong Hyo KhoPratima Nangia-MakkerVitaly BalanVictor HoganLarry TaitYi WangAvraham Raz

breast cancer cellstumor biologysignaling pathwayscancer researchcancer biologycell biologycell signalingautocrine motility factorsignal transductionbreast cancer

Data From Galectin-3 Cleavage Alters Bone Remodeling: Different Outcomes in Breast and Prostate Cancer Skeletal Metastasis. (2023)

Kosei NakajimaDhong Hyo KhoTakashi YanagawaYosuke HarazonoVictor HoganWei ChenRouba Ali-FehmiRohit MehraAvraham Raz

Kenneth V. Honn, Ph.D. (1946–2023). Cancer and Metastasis Reviews (2023)

Avraham RazJohn C. CrissmanCaryn Volpe

metastasiscancer researchradiation oncologyoncologycancer biology

Supplementary Figure 1 From Down-Regulation of Phosphoglucose Isomerase/Autocrine Motility Factor Results in Mesenchymal-To-Epithelial Transition of Human Lung Fibrosarcoma Cells. (2023)

Tatsuyoshi FunasakaHuankai HuTakashi YanagawaVictor HoganAvraham Raz

Supplementary Figure 1 From Phosphoglucose Isomerase/Autocrine Motility Factor Mediates Epithelial and Mesenchymal Phenotype Conversions in Breast Cancer. (2023)

Tatsuyoshi FunasakaVictor HoganAvraham Raz

Supplementary Figure 1 From Regulation of Phosphoglucose Isomerase/Autocrine Motility Factor Activities by the Poly(Adp-Ribose) Polymerase Family-14. (2023)

Takashi YanagawaTatsuyoshi FunasakaSoichi TsutsumiHuankai HuHideomi WatanabeAvraham Raz

enzymesendocrinologyprotein sciencemolecular regulationbiochemistrypharmacologymembrane biologyphysiologymolecular physiology

Supplementary Figure 3 From Autocrine Motility Factor Promotes Her2 Cleavage and Signaling in Breast Cancer Cells. (2023)

Dhong Hyo KhoPratima Nangia-MakkerVitaly BalanVictor HoganLarry TaitYi WangAvraham Raz

breast cancer cellssignaling pathwayscancer researchcancer biologycell biologycell signalingautocrine motility factorsignal transductiongene expressionbreast cancer

Supplementary Materials and Methods From Galectin-3 Cleavage Alters Bone Remodeling: Different Outcomes in Breast and Prostate Cancer Skeletal Metastasis. (2023)

Kosei NakajimaDhong Hyo KhoTakashi YanagawaYosuke HarazonoVictor HoganWei ChenRouba Ali-FehmiRohit MehraAvraham Raz

Supplementary Tables 1-2 From Racial Disparity in Breast Cancer and Functional Germ Line Mutation in Galectin-3 (Rs4644): A Pilot Study. (2023)

Chimeric Galectin-3 and Collagens: Biomarkers and Potential Therapeutic Targets in Fibroproliferative Diseases. Journal of Biological Chemistry (2022)

Pratima Nangia-MakkerVictor HoganVitaly BalanAvraham Raz

1
2
3
4
5
26
10 / page

Similar Faculty Members

Rafael Fridman

Institution

Wayne State University

proteases

cancer biology

Salvatore Vincent Pizzo

Institution

Duke University

pharmacology

biochemistry

Ann Richmond, Ph.D

Institution

Vanderbilt University

immunology

molecular cancer

Kermit Carraway

Institution

University of California, Davis

pharmacological research

toxicological mechanism

Donald McDonnell

Institution

Duke University

pharmacology

endocrinology

Amato J. Giaccia

Institution

Stanford University

radiation oncology

cancer biology

Sanjay Srivastava

Institution

University of Louisville

volatile organic compounds

free radical biology

Lu Cai

Institution

University of Louisville

heavy metals

health science

Channing Der

Institution

University of North Carolina at Chapel Hill

drug targeting

anti-cancer agent

Robert J. Coffey, M.D

Institution

Vanderbilt University

gi neoplasia

oncogene

Similar Faculty Members

Rafael Fridman

Institution

Wayne State University

proteases

cancer biology

Salvatore Vincent Pizzo

Institution

Duke University

pharmacology

biochemistry

Ann Richmond, Ph.D

Institution

Vanderbilt University

immunology

molecular cancer

Kermit Carraway

Institution

University of California, Davis

pharmacological research

toxicological mechanism

Donald McDonnell

Institution

Duke University

pharmacology

endocrinology

Amato J. Giaccia

Institution

Stanford University

radiation oncology

cancer biology

Sanjay Srivastava

Institution

University of Louisville

volatile organic compounds

free radical biology

Lu Cai

Institution

University of Louisville

heavy metals

health science

Channing Der

Institution

University of North Carolina at Chapel Hill

drug targeting

anti-cancer agent

Robert J. Coffey, M.D

Institution

Vanderbilt University

gi neoplasia

oncogene